Changes in Plasma Phospholipid Metabolism Are Associated with Clinical Manifestations of Systemic Sclerosis
Systemic sclerosis (SSc) is an autoimmune disease with fibrosis of the skin and/or internal organs, causing a decrease in quality of life and survival. There is no causative therapy, and the pathophysiology of the SSc remains unclear. Studies showed that lipid metabolism was relevant for autoimmune...
Guardado en:
Autores principales: | Marija Geroldinger-Simić, Thomas Bögl, Markus Himmelsbach, Norbert Sepp, Wolfgang Buchberger |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/87f8e91db1994fd79727dc576bf1909f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A rare case report of neonatal calcinosis cutis induced by distant and delayed extravasation of intravenous calcium gluconate
por: Kwang Hyeon Ahn, et al.
Publicado: (2021) -
The Updated Role of Ultrasound in Assessing Dermatological Manifestations in Systemic Sclerosis
por: Ruaro B, et al.
Publicado: (2021) -
Bisphosphonates for the Treatment of Calcinosis Cutis—A Retrospective Single-Center Study
por: Lilian Rauch, et al.
Publicado: (2021) -
Progesterone Aggravates Lung Fibrosis in a Mouse Model of Systemic Sclerosis
por: Fatemeh Vafashoar, et al.
Publicado: (2021) -
Effectiveness and safety of oxycodone/naloxone in the management of chronic pain in patients with systemic sclerosis with recurrent digital ulcers: two case reports
por: Ughi N, et al.
Publicado: (2016)